Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
|
CN |
Shenzhen Weiguang Biological Products Co Ltd
Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. The company is headquartered in Shenzhen, Guangdong and currently employs 759 full-time employees. The company went IPO on 2017-06-16. The Company’s primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The firm mainly operates its businesses in domestic market.
Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. The company is headquartered in Shenzhen, Guangdong and currently employs 759 full-time employees. The company went IPO on 2017-06-16. The Company’s primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The firm mainly operates its businesses in domestic market.
